
Summary for Generic Name: QUETIAPINE FUMARATE
|
Tentative approvals for QUETIAPINE FUMARATE
|
| Applicant | Tradename | Generic Name | NDA | Approval Date | Type | RLD | Patent Number | Product | Substance | Delist Req. | Patent Expiration | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Astrazeneca | SEROQUEL XR | quetiapine fumarate | 022047 | Aug 11, 2008 | RX | No | 4,879,288*PED | Y | Mar 26, 2012 | |||
| Astrazeneca | SEROQUEL XR | quetiapine fumarate | 022047 | Aug 11, 2008 | RX | No | 5,948,437*PED | Y | Nov 28, 2017 | |||
| Astrazeneca | SEROQUEL XR | quetiapine fumarate | 022047 | Aug 11, 2008 | RX | No | May 17, 2010 |
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Copyright © 2000-2010, thinkBiotech LLC.